Publications by authors named "Martin Erlanson"

Claim this Profile
E
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
Elisa Jacobsen Pulczynski, Mikkel Runason Simonsen, Outi Kuittinen, Unn-Merete Fagerli, Martin Erlanson

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
Olivia Carlund, Elina Thörn, Pia Osterman, Maja Fors, Andy Dernstedt, Martin Erlanson

Clin Epigenetics· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
Anne Andersson, Gunilla Enblad, Martin Erlanson, Ann-Sofie Johansson, Daniel Molin

Ups J Med Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.
Zahra Haider, Mattias Landfors, Irina Golovleva, Martin Erlanson, Kjeld Schmiegelow

Blood Cancer J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius, Magnus Björkholm, Gunilla Enblad, Martin Erlanson

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.
Maysaa Abdulla, Peter Hollander, Tatjana Pandzic, Larry Mansouri, Susanne Bram Ednersson, Martin Erlanson

Am J Hematol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, therapy response, and outcome of 51 adult patients with hematological malignancy-associated hemophagocytic lymphohistiocytosis: a single institution experience.
Fryderyk Lorenz, Monika Klimkowska, Ewa Pawłowicz, Agnes Bulanda Brustad, Martin Erlanson

Leuk Lymphoma· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.
Larry Mansouri, Daniel Noerenberg, Emma Young, Elena Mylonas, Maysaa Abdulla, Martin Erlanson

Blood· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas.
Eva Kimby, Björn Östenstad, Peter Brown, Hans Hagberg, Martin Erlanson

Leuk Lymphoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group.
Elisa J Pulczynski, Outi Kuittinen, Martin Erlanson, Hans Hagberg, Alexander Fosså

Haematologica· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
Francesco d'Amore, Thomas Relander, Grete F Lauritzsen, Esa Jantunen, Hans Hagberg, Martin Erlanson

J Clin Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term risk of infections in Hodgkin lymphoma long-term survivors.
Anne Andersson, Gunilla Enblad, Anita Gustavsson, Martin Erlanson, Hans Hagberg

Br J Haematol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab.
Björn Engelbrekt Wahlin, Christer Sundström, Harald Holte, Hans Hagberg, Martin Erlanson

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden.
Frida Kasteng, Martin Erlanson, Hans Hagberg, Eva Kimby, Thomas Relander

Acta Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
Johan Linderoth, Patrik Edén, Mats Ehinger, Jeanette Valcich, Mats Jerkeman, Martin Erlanson

Br J Haematol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
Johan Linderoth, Mats Ehinger, Mats Jerkeman, Pär-Ola Bendahl, Måns Akerman, Martin Erlanson

Leuk Lymphoma· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
Johan Linderoth, Mats Ehinger, Måns Akerman, Eva Cavallin-Ståhl, Gunilla Enblad, Martin Erlanson

Eur J Haematol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma.
Gustaf Hedström, Mattias Berglund, Daniel Molin, Marie Fischer, Gunnar Nilsson, Martin Erlanson

Br J Haematol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma.
Mattias Berglund, Gunilla Enblad, Ulf Thunberg, Rose-Marie Amini, Christer Sundström, Martin Erlanson

Mod Pathol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
Mattias Berglund, Ulf Thunberg, Rose-Marie Amini, Majlis Book, Göran Roos, Martin Erlanson

Mod Pathol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
Richard Rosenquist, Göran Roos, Martin Erlanson, Ralf Küppers, Andreas Bräuninger

Eur J Haematol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas.
Gunilla Enblad, Hans Hagberg, Martin Erlanson, Jeanette Lundin, Anja Porwit MacDonald

Blood· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exhaled nitric oxide is highly increased in a case of Hodgkin's disease.
Thomas Holmkvist, Martin Erlanson, Pekka Meriläinen, Marieann Högman

Acta Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers.
Barbro K Linderholm, Birgitta Lindh, Lars Beckman, Martin Erlanson, Kent Edin

Clin Breast Cancer· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and intermediate stage Hodgkin's lymphoma--report from the Swedish National Care Programme.
Daniel Molin, Gunilla Enblad, Anita Gustavsson, Tor Ekman, Martin Erlanson

Eur J Haematol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis